Search
  • 網站搜尋
亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。
返回搜索結果

Knock-in mouse model with labeled insulin provides essential tool for diabetes research and drug development


總結

Argiris Efstratiadis, Ph.D.


技術優勢

Directly labels insulin in vivo such that the GFP is restricted only to the cells where insulin is foundAll regulatory elements in the insulin gene are kept intact, so expression can’t be falsely altered by other local factors (like in transgenic mice) Any genetic or environment modifications to the endogenous insulin will be accurately represented by the GFP labelPatent information:Patent PendingTech Ventures Reference: IR 2363


技術應用

Animal model to investigate genetic and environmental factors that cause insulin level and expression changes Ability to track insulin production and secretion will provide insight into effectiveness of various drug compounds for diabetes treatmentFurther in vivo investigation into insulin-secreting beta cells, which are labeled by the GFPThe labeling of cells that interact with insulin will allow precise extraction of these cells for ex vivo experimentsIdentification of novel proteins that interact with insulin, which may serve as therapeutic targets for diabetes


詳細技術說明

Argiris Efstratiadis, Ph.D.


國家/地區

美國

欲了解更多信息,請點擊 這裡
Business of IP Asia Forum
桌面版